Mortality impact of further delays in active targeted antibiotic therapy in bacteraemic patients that did not receive initial active empiric treatment: Results from the prospective, multicentre cohort PROBAC – INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

de la Rosa-Riestra, S; Pérez-Crespo, PMM; Rodríguez, MTP; Sousa, A; Goikoetxea, J; Iglesias, JMR; Arminanzas, C; López-Hernández, I; López-Cortés, LE; Rodríguez-Baño, J – 2024 – 10.1016/j.ijid.2024.107072

Role of IP-10 to Predict Clinical Progression and Response to IL-6 Blockade With Sarilumab in Early COVID-19 Pneumonia. A Subanalysis of the SARICOR Clinical Trial – OPEN FORUM INFECTIOUS DISEASES

Trigo-Rodriguez, M; Carcel, S; Navas, A; Espindola-Gomez, R; Garrido-Gracia, JC; Moreno, MAE; Leon-Lopez, R; Perez-Crespo, PMM; Alonso, EA; Vinuesa, D; Romero-Palacios, A; Perez-Camacho, I; Gutierrez-Gutierrez, B; Martinez-Marcos, FJ; Fernandez-Roldan, C; Leon, E;...